Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models

Tal Feldman; Iris Grossman-Haham; Yoav Elkis; Patrick Vilela; Neta Moskovits; Iris Barshack; Tomer M. Salame; Deborah Fass; Tal Ilani

doi:10.18632/oncotarget.27764

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models

PDF | How to cite

Oncotarget. 2020; 11:3687-3687. https://doi.org/10.18632/oncotarget.27764

Metrics: PDF 1143 views | ?

Tal Feldman¹, Iris Grossman-Haham¹, Yoav Elkis², Patrick Vilela¹, Neta Moskovits³, Iris Barshack⁴, Tomer M. Salame⁵, Deborah Fass¹ and Tal Ilani¹

¹ Department of Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel
² Almog Diagnostic, Shoham 6081513, Israel
³ Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
⁴ Institute of Pathology, Sheba Medical Center Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
⁵ Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot 7610001, Israel

Published: October 06, 2020

Copyright: © 2020 Feldman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: The funding information has been updated. The correct listing is given below:

This work was supported by the European Research Council [grants number 310649 and 825076]

Original article: Oncotarget. 2020; 11:386–398. DOI: https://doi.org/10.18632/oncotarget.27438.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27764

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models